Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 |
|---|---|---|---|
| Research and development | 21M | 16M | 20M |
| Selling, general and administrative | 17M | 11M | 7M |
| Operating expenses | 38M | 27M | 28M |
| Pre-tax income | −39M | −26M | −29M |
| Income tax | 19,091 | 1,804 | 36,423 |
| Net income | −39M | −26M | −28M |
| Earnings per share | −1.03 | −0.76 | −1.17 |
| Earnings per share, diluted | −1.03 | −0.76 | −1.17 |
| Weighted average shares | 40M | 34M | 24M |
| Weighted average shares, diluted | 40M | 34M | 24M |
| Metric | 18/08/2026 | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|---|
| Cash and equivalents | — | 81M | 33M | 19M | 18M |
| Current assets | — | 85M | 34M | 20M | — |
| Property, plant and equipment | — | 834,429 | 357,893 | 409,587 | — |
| Total assets | — | 86M | 35M | 20M | — |
| Current liabilities | — | 6M | 3M | — | — |
| Total liabilities | — | 6M | 3M | 19M | — |
| Equity | — | 82M | 33M | 892,326 | 7M |
| Shares outstanding | — | 52M | 36M | 27M | — |
| Shares issued | — | 52M | 36M | 27M | — |
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 |
|---|---|---|---|
| Operating cash flow | −29M | −30M | −21M |
| Depreciation and amortisation | 237,717 | 171,719 | 155,527 |
| Share-based compensation | 9M | 3M | 1M |
| Investing cash flow | −588,947 | −75,159 | −73,377 |
| Financing cash flow | 76M | 46M | 21M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator